In recent years, the rapid diagnostic kits market has drawn intense attention from healthcare stakeholders, driven by the urgent need for faster disease detection, decentralization of testing, and consumer demand for at‑home diagnostics. Over the 2021–2031 period, this market is expected to undergo robust evolution, shaped by innovations in assay technologies, shifting application...